Medvantx Pharmacy at UPS Louisville Facility Completes Significant Expansion to Meet Increasing Demand for Direct-to-Patient Prescription Orders

Medvantx ‘end of runway’ fulfillment operations within UPS Supply Chain Solutions campus has surpassed $3.7 billion in pharmaceutical inventory management

San Diego, January 13, 2020 – Medvantx, Inc., a leading provider of ecommerce pharmacy and final-mile delivery solutions, today announced a major expansion and technology upgrades of its embedded, end-of-runway pharmacy at the UPS Supply Chain Solutions campus in Louisville, KY. The expansion doubles Medvantx’s pharmacy space to support the company’s continued growth; Medvantx recently surpassed $3.7 billion in pharmaceutical inventory management annually.

The location of the Medvantx end-of-runway pharmacy, adjacent to the UPS Worldport® global air hub, enables the company to fill prescriptions and ship medicines for expedited delivery to patients or doctors’ offices via the UPS air network. With an order cutoff time of 1AM ET, Medvantx has one of the industry’s most comprehensive shipping capabilities.

“As Medvantx undergoes tremendous growth, an agile, scalable and best-in-class supply chain is absolutely critical,” said Robert J Feeney, Jr., CEO of Medvantx. “Our pharmacy services at UPS Supply Chain Solutions, combined with our innovative relationship with UPS staff, help provide Medvantx with the resources needed to meet consumer expectations for more rapid, on-time delivery of medications.”

Medvantx’s expanded pharmacy space is fully licensed and cGMP-compliant, and supports a full range of distribution and warehousing services — including secured storage, packaging and labeling — for temperature-sensitive healthcare products such as specialty pharma and controlled substances.

“Direct-to-patient services are a growing trend,” said Wes Wheeler, president of UPS Healthcare and Life Sciences. “We are pleased to help customers like Medvantx meet specialized, priority needs for critical therapies with a robust supply chain that enables better health and business growth.”

“Speed to therapy can be a significant contributor to patient engagement and adherence, especially for patients beginning a new drug regimen,” Feeney added. “One of our goals at Medvantx is to increase our fulfillment and delivery speed to foster greater adherence for patients.”

About Medvantx, Inc. Medvantx, Inc., partners with pharmaceutical and biopharmaceutical companies to bring medicines to patients with a direct-to patient platform that streamlines delivery, minimizes cost and enhances the patient experience. Managing the entire process from end to end, Medvantx offers e-commerce solutions, pharmacy services and innovative final-mile fulfillment. Licensed

in all 50 states and handling more than $7.5 billion in prescriptions annually, Medvantx has been redefining pharmacy for over 15 years.

###

Media contact:

Anne King
King PR Anne.king@kingpr.net
646 281 5229

Medvantx Adds Chief Technology Officer to its Senior Management Team

SAN DIEGO, Tuesday, January 07, 2020 –Medvantx, Inc., the leading provider of ecommerce and final mile delivery solutions, announces that Jeremy (“Jerry”) V. Gross has joined the company as Chief Technology Officer (CTO). This newly created position will focus on the further development of the company’s proprietary ecommerce, pharmacy and final mile delivery platform.

“Jerry’s unique combination of expertise from the financial technology sector pharmaceutical and logistics industries, is a key addition to Medvantx, and will help our customers navigate a rapidly changing healthcare marketplace,” said Robert J Feeney, Jr., founder and CEO of Medvantx.

Gross brings a 30+ year track record of leading development teams and leveraging emerging technologies to create disruptive innovation within biopharma, healthcare and the financial technology industries. Previously, he held senior technology, innovation and incubation leadership roles at Amgen, McKesson, Intuit and JPMorgan. Gross has lead the design, development and commercialization of e-commerce, complex back-end logistics systems and cloud-based data solutions for pharmaceutical and global distribution companies, as well as early online banking and e-Commerce platforms in financial services.

“Medvantx is one of the early pioneers in the direct-to-patient space and has the experience and infrastructure necessary to support large scale digital transformation strategies for pharmaceutical companies,” said Jerry Gross, chief technology officer at Medvantx. “I’m thrilled to join the Medvantx team, and to work with leading developers and technology partners to identify and pilot emerging technologies in consumer engagement, machine learning and big data to bring advances to the healthcare industry.”

As CTO, Gross will lead Medvantx newly created business unit dedicated to advancing the company’s technology platform, and identify new technology-based solutions for the company’s clients. This business unit will be located in San Diego to encourage collaboration with the local digital healthcare and technology community.

About Medvantx, Inc.

Medvantx, Inc., partners with pharmaceutical and biopharmaceutical companies to bring medicines to patients with a direct-to patient platform that streamlines delivery, minimizes cost and enhances the patient experience. Managing the entire process from end to end, Medvantx offers e-commerce solutions, pharmacy services and innovative final-mile fulfillment. Licensed in all 50 states and handling more than $7.5 billion in prescriptions annually, Medvantx has been redefining pharmacy for over 15 years.

Media contact:

Anne King
(212)779-8975
anne.king@kingpr.net

Medvantx contact:

Bobbie Montgomery
(610)740-4879
bobbie@montgomery@medvantx.com

Source:
Medvantx, Inc.

Related Links:
www.medvantx.com